Evogene Ltd. logo
Evogene Ltd. EVGN
$ 0.32 -8.57%
report update icon

Quarterly report 2022-Q4
added 11-19-2026

Evogene Ltd. Market Cap | EVGN

As of November 22, 2026 Evogene Ltd. has a market cap of $ 2.52 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Evogene Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.38 M 6.78 M 3.4 M 2.86 M 66.3 M 132 M 39.1 M 51 M 78.8 M 126 M 167 M 211 M 342 M 95.1 M 72.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
342 M 2.86 M 93.4 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
27.2 M - -0.9 % $ 36.5 M usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
291 M $ 0.59 -11.3 % $ 50.3 M usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
4.45 B - - $ 3.48 B usaUSA
Axon Enterprise Axon Enterprise
AXON
30.6 B $ 291.02 -5.2 % $ 22.7 B usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
17 M - -46.98 % $ 3.57 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.72 M - - $ 7.46 M israelIsrael
Evelo Biosciences Evelo Biosciences
EVLO
27 M - -14.46 % $ 27.9 M usaUSA
Morphic Holding Morphic Holding
MORF
1.52 B - - $ 2.42 B usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
72.7 M - -15.0 % $ 3.04 M usaUSA
Biogen Biogen
BIIB
29.4 B $ 249.55 0.98 % $ 36.6 B usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
122 B $ 58.74 0.69 % $ 119 B usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
3.11 M - -9.21 % $ 2.55 M usaUSA
IGM Biosciences IGM Biosciences
IGMS
84.7 M - - $ 76.9 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
211 M - - $ 216 M usaUSA
Rubius Therapeutics Rubius Therapeutics
RUBY
11.7 M - -33.55 % $ 7.81 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
2.56 B - - $ 3.3 B usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
3.15 M - -37.48 % $ 476 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
8.32 M - -9.72 % $ 5.89 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
672 M - 1.02 % $ 90.8 M britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
127 M - - $ 154 M usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
312 M - - $ 300 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
706 M - - $ 643 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
1.39 B - - $ 2.6 B usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
165 M - -8.44 % $ 3.4 M usaUSA
NanoViricides NanoViricides
NNVC
30.3 M $ 1.15 -2.54 % $ 23.2 M usaUSA
GT Biopharma GT Biopharma
GTBP
2.59 M $ 2.93 -7.86 % $ 16.2 M usaUSA
Zymeworks Zymeworks
ZYME
845 M $ 26.41 -1.68 % $ 1.36 B canadaCanada
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
327 M $ 0.84 16.41 % $ 50.4 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
8.52 M $ 0.51 1.61 % $ 5.64 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
7.55 M $ 50.7 -1.48 % $ 6.09 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
2.82 B $ 9.03 -4.14 % $ 1.26 B franceFrance
Precision BioSciences Precision BioSciences
DTIL
64.6 M $ 7.37 6.66 % $ 94.5 M usaUSA
Exelixis Exelixis
EXEL
11.7 B $ 64.59 -1.88 % $ 17.5 B usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
169 M $ 13.09 -2.68 % $ 374 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
116 M $ 0.85 -4.67 % $ 56.8 M usaUSA
BioNTech SE BioNTech SE
BNTX
22 B $ 80.87 -0.63 % $ 19.5 B germanyGermany
Alkermes plc Alkermes plc
ALKS
5.13 B $ 44.89 -2.79 % $ 7.39 B irlandaIrlanda
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
1.24 B $ 68.6 -0.77 % $ 1.38 B usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
1.13 M $ 0.11 -7.75 % $ 178 K usaUSA
AC Immune SA AC Immune SA
ACIU
287 M $ 1.98 -7.28 % $ 199 M schweizSchweiz
Atara Biotherapeutics Atara Biotherapeutics
ATRA
73.6 M $ 6.51 2.6 % $ 81.7 M usaUSA
Allogene Therapeutics Allogene Therapeutics
ALLO
545 M $ 0.63 -5.62 % $ 139 M usaUSA
Altimmune Altimmune
ALT
318 M $ 1.33 -6.03 % $ 117 M usaUSA
AnaptysBio AnaptysBio
ANAB
1.59 B $ 46.65 -1.58 % $ 1.35 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
13.1 B $ 252.39 -1.39 % $ 15.3 B danmarkDanmark
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
217 M $ 7.42 -2.37 % $ 203 M israelIsrael
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
1.86 B $ 14.7 -1.28 % $ 1.98 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
322 M $ 0.91 -6.96 % $ 242 M britainBritain
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
426 M $ 3.97 0.89 % $ 324 M usaUSA